Evidence map›Paper›PMID 18468897›Full record

ArticleTrends in cell biology2008

Special delivery from mitochondria to peroxisomes.

Uwe Schumann, Suresh Subramani

Abstract read
In one paragraph

Article in Trends in cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  2. Review
  3. Review
  4. Hydrogen Sulfide (HBiomolecules · 2024
    Review
  5. Lysosomes in retinal health and disease.Trends in neurosciences · 2023
    Review
  6. Mitochondrial-Derived Vesicles: The Good, the Bad, and the Ugly.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Functions of ROS in Macrophages and Antimicrobial Immunity.Antioxidants (Basel, Switzerland) · 2021
    Review
  11. The Role of HAdvances in experimental medicine and biology · 2021
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease.Oxidative medicine and cellular longevity · 2018
    Review
  17. Article
  18. Heme Mobilization in Animals: A Metallolipid's Journey.Accounts of chemical research · 2016
    Review
  19. Article
  20. Signaling molecules: hydrogen sulfide and polysulfide.Antioxidants & redox signaling · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Uwe SchumannSection of Molecular Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
Suresh Subramani

Funding

Targeting of proteins into peroxisomesR37DK041737 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUBRAMANI, SURESH · 2004 to 2013
$5.3M
NIDDK NIH HHS R37 DK041737
6 · The paper itself

Abstract

Inter-organellar communication and interactions are necessary and accepted consequences of the segregation of biochemical functions into subcellular organelles. Recently, Heidi McBride and her collaborators found a novel link between mitochondria and peroxisomes in their discovery of mitochondria-derived vesicles (MDVs), which appear to fuse with a fraction of pre-existing peroxisomes in mammalian cells. We discuss the potential role of this vesicle population in the context of pathways for the exchange of metabolites and/or macromolecules between these compartments.

Indexed as

AnimalsHumansIntracellular MembranesLipidsMembrane PotentialsMitochondriaModels, BiologicalOrganellesPeroxisomesProteomicsSaccharomyces cerevisiaeSubcellular FractionsLipids

Identifiers

PMID18468897
PMCPMC3697091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.